Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026
Go back to Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026| Capstone Therapeutics Corp (NASDAQ: CAPS) | Delayed: 0.26 -0.01 (3.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.27 | 52 Week High | $0.15 | |||
| Open | $0.27 | 52 Week Low | $0.04 | |||
| Day High | $0.27 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $-0.27 | |||
| Volume | 38,836 | |||||
